Back

Medscape, LLC

  • Polycystic Kidney Diseases

Medscape Now! Optimizing Outcomes in Polycystic Kidney Disease: Risk Stratification and Disease-Modifying Therapies

The goal of this activity is for learners to be better able to evaluate and implement emerging data and guidelines into patient care, including risk stratification, individualized management strategies, and appropriate use of disease-modifying therapies for patients with ADPKD and ARPKD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

ABIM — Medical KnowledgeUp to 0.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • MOC · Up to 0.25 points
  • Released
    May 18, 2026
  • Last day to claim credit
    May 18, 2029 3 years left